LGC has announced the addition of ec23, a stable synthetic retinoid used for stem cell differentiation, to its portfolio of life-science research and drug-discovery products.
ec23 is a proprietary molecule designed by the scientists the Reinnervate life-sciences company, who have agreed an arrangement with LGC for the distribution of ec23 to scientists across Europe.
A synthetic molecule, ec23 is designed to mediate the controlled and reproducible differentiation of cells in culture.
ec23 has been shown to be a potent inducer of neurogenesis and is entirely stable, enabling it to modulate cell differentiation predictably and consistently.
With many other naturally occurring retinoids, degradation over time and on exposure to light leads to difficulties in assessing the concentration that researchers need to use in their cell differentiation experiments.
This can be eliminated through the use of ec23, which for ease of use is supplied in a clear glass vial.
